Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has sold an aggregate of 21,607,878 shares of the ...
Shares of Sana Biotechnology declined after the company said it sold shares of its common stock through its at-the-market facility for $69 million in net proceeds. The stock ticked down 2.6% to $3.06 ...
PDS Biotechnology (NASDAQ:PDSB) reported first-quarter financial results on Wednesday. The transcript from the company's ...
The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a ...
Marianne De Backer took over as CEO of Vir in 2023. Since then she has shuttered three sites and laid off more than a third ...
Healthcare Investors lagged its benchmark as biotech faced regulatory hurdles and market rotation. Read the full analysis for ...
Focused on immunology-based therapies for infectious diseases, this biotech company reported a notable insider sale in recent ...
LIXTE Biotechnology Holdings, Inc. ('LIXTE” or the 'Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech ...
LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing ...
Bank of America Global Healthcare Conference 2026 May 12, 2026 5:20 PM EDTCompany ParticipantsSteven Harr - President, ...
Yenssen Biotech opens international distributor recruitment for Dermlin wound healing series, Ulceloocin oral ulcer ...
EAST PRINCETON, N.J. (AP) — EAST PRINCETON, N.J. (AP) — PDS Biotechnology Corporation (PDSB) on Wednesday reported a loss of $7.3 million in its first quarter. The East Princeton, New Jersey-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results